ArticleElectrophoresis2014

Tissue phosphoproteomics with PolyMAC identifies potential therapeutic targets in a transgenic mouse model of HER2 positive breast cancer.

Adam C Searleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.